- INJ price compresses within a symmetrical triangle, nearing a decisive breakout zone.
- 50-day SMA at $13.31 and 200-day EMA at $13.55 form a tight resistance cluster.
- Volume and RSI suggest bullish momentum, with price targeting $15–$26 on breakout.
Injective (INJ) is tightening within a key symmetrical triangle, nearing a crucial breakout point. With rising volume and strong weekly gains, price action suggests mounting pressure. Traders are watching closely as INJ approaches a potential move that could ignite a fresh bullish trend.
Triangle Apex Builds Pressure Near Critical Resistance
Injective (INJ) is pressing up against a critical breakout zone, with its daily chart forming a classic symmetrical triangle pattern. Price has been squeezing between a rising support and a descending resistance, and now trades just above $13.20—right at the triangle’s narrowing tip. This kind of price compression often signals that a big move is coming.
                                             Source Jonathan Carter Via X
The 50-day SMA at $13.31 and the 200-day EMA at $13.55 are forming a tight barrier for Injective as it presses against the resistance zone. This cluster is at the triangle’s apex, making it a level to watch. If INJ breaks through it could trigger a sharp move upward.
Short-term targets are between $14.20 and $14.95, aligning with a main Fibonacci retracement ,this will be depedent on Momentum and volume .
Momentum Indicators and Volume Support Breakout Setup
Momentum is shifting in favor of the bulls, with the RSI at 52,and MACD above its signal line since last Thursday, supporting the bullish outlook.This happened due to growing buying pressure.
Volume stayed steady, but spikes on October 4 and 5 stand out for they occurred during price climbs, a sign of accumulation by larger players. INJ is holding above its 9-period EMA at $13.16, with the RSI at 59 , this shows a healthy, sustained momentum without entering overbought territory yet.
                                               Source CryptoRank
Market Cap Movement Reflects Growing Investor Confidence
Injective’s recent market cap performance is reinforcing the bullish outlook ,after climbing from just under $1.2 billion to a peak of $1.3 billion. Despite a brief dip, it is consistently holding above the $1.2 billion mark—a strong indicator that investor confidence remains intact.
This growth doesn’t look like a quick pump-and-dump,instead it shows signs of real accumulation, likely from larger players,who are positioning for a potential breakout ahead. As the market cap edges closer to the late-2024 all time higher range, Injective could be on the verge of a longer-term move.
Price is now tightly squeezed near the symmetrical triangle apex, with $13.55 acting as the next resistance. A decisive breakout could open doors to $15.00 and $18.50,while failure could send INJ back toward $11.60.
